Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol Anesthesia on Postoperative Delirium in Neurosurgical Patients
NCT06115031Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Incidence of postoperative delirium. Started Nov 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06115031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06115031.